Pharmaceuticals

Delhi HC rejects Reckitt Benkiser's claims against Wyeth

11 Aug 2009

India to crack down on fake Chinese drugs

11 Aug 2009

Merck, Schering-Plough shareholders approve $41-billion deal

10 Aug 2009

Pfizer, Mylan lower HIV drug prices for drug-resistant patients

08 Aug 2009

Aurobindo wins FDA nod for generic drug

08 Aug 2009

Dr Reddy's Lab launches skin patch pain reliever in India

06 Aug 2009

FDA bans Teva Animal Health’s veterinary drugs

03 Aug 2009

Sun Pharma settles Ethyol dispute with MedImmune

03 Aug 2009

Pfizer settles Trovan cases; pays $75 million to Nigerian state

31 Jul 2009

Sanofi-Aventis to acquire Merck's Merial stake for $4 billion

30 Jul 2009

Mylan says FDA approves its drug production

29 Jul 2009

Wockhardt sells its nutrition businesses to Abbott for $130 million

28 Jul 2009

Chinese-made fake Indian drugs hurt industry's image in Africa

28 Jul 2009

Sanofi-Aventis to acquire Shantha Biotech for Rs3,757 crore

27 Jul 2009

France’s biggest drug maker, Sanofi-Aventis, will acquire majority control of Indian pioneering vaccines maker Shanta Biotechnics valuing the unlisted Indian company at nearly Rs3,757 crore.

Azad hints at nexus between private-public vaccine units

25 Jul 2009

Dr Reddy's Q1 revenue up 21 per cent at Rs1,818 crore; eyes Rs15,000 crore turnover by 2012-13

23 Jul 2009

Bristol-Myers to acquire biotechnology company Medarex for $2.4 billion

23 Jul 2009

US drugmaker Bristol-Myers Squibb said yesterday that it is acquiring biotechnology company Medarex Inc, a for $2.4 billion to expand its oncology and immunology pipeline

Merck’s Q2 profit falls, but beats expectations

22 Jul 2009

Dr Reddy's first quarter 2009-10 net doubles to Rs239 crore

21 Jul 2009

EC approves Pfizer's $68-billion acquisition of Wyeth

18 Jul 2009

The European Commission has approved Pfizer's acquisition and merger of Wyeth Laboratories subject to Pfizer divesting certain animal health assets in the EU

Daiichi's 'low' bid for Zenotech faces new hurdles

16 Jul 2009

Merck, Schering-Plough settle Vyotorin dispute with states

16 Jul 2009

Merck and Schering-Plough yesterday have agreed to pay 35 states $5.4 million to settle allegations of delaying announcing the negative findings on their anti-cholesterol drug Vytorin

No decision yet on bringing essential drug under price control

11 Jul 2009

Streptokinase, A Life Saving Drug, Developed in collaboration with CSIR launched for Indian Market

11 Jul 2009

Cadila Pharmaceuticals launches joint venture with Novavax in India

10 Jul 2009